Skip to main content
Sunday 5 February 2023
twitter linkedin facebook rss
User account menu
  • Sign in
  • Sign up
Home
Pharmaphorum menu first category
  • News
  • Views & Analysis
  • Deep Dive
  • Webinars
  • Podcasts
  • Videos
  • White Papers
  • Events
close
    SECTION
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Videos
    • White Papers
    • Events
Channels
    Channels
    • Sales & Marketing
    • R&D
    • Digital
    • Market Access
    • Oncology
    • Patients
    • Spotlight
Channels
  • Sales & Marketing
  • R&D
  • Digital
  • Market Access
  • Oncology
  • Patients
  • Spotlight
    SUB NAVIGATION
    • Live Coverage
    • Partner Content
    • About us
    • Work for us
    • Contribute
    • Contact us
    • Advertise

Newsletters and Deep Dive digital magazine

 
 
Sign up
twitter linkedin facebook rss
Sign in

Disease spotlight: LHON

Views & Analysis
Card image cap
Image
pharmaphorum editor
pharmaphorum Editor
26 January, 2018
FacebookTwitterLinkedin
Bookmark this


Healthcare
Card image cap

NHS Innovation and Life Sciences Commission – 2022 Report La...

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the

News
Card image cap

Sanofi drops BTK drug tolebrutinib in myasthenia gravis

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso

Oncology
Card image cap
Sponsored

How can digital and AI optimise the delivery of patient supp...

How can digital and AI optimise the delivery of patient support programs in cancer?

Digital
Card image cap

Create, approve, deploy: supercharge comms with modular cont...

Each year, pharma and life sciences invest large amounts of time and money in creating content designed to attract HCPs and call them to action.

Sales & Marketing
Card image cap
Sponsored

Empowering MSLs to be the kings of Pharma’s New Frontier

The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector. But, al

White Papers
Card image cap
Sponsored

Sales coaching: preparing for the new reality in pharma

COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessme

Oncology
Card image cap
Partner Content

2nd Next Generation Kinase Inhibitors Summit

Industry-dedicated summit focused on advancing the best-in-class kinase inhibitor products

R&D
Card image cap
Partner Content

5th Cell Engager Summit

The 5th Annual Cell Engager Summit is back in Boston, MA this year

 
 

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Category : Views & Analysis /

Editor’s Picks

  1. Welcome to the new pharmaphorum
  2. Roche names Teresa Graham as its new pharma chief
  3. How can digital and AI optimise the delivery of support?
  4. How Moderna kept diversity in mind amid vaccine development
  5. JP Morgan 2023 – Alexandre LeVert
News
Card image cap

Sanofi drops BTK drug tolebrutinib in myasthenia gravis

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso

Patients
Card image cap

How Moderna kept diversity in mind amid vaccine development

In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.

Pharmaphorum Menu
  • Digital
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Market Access
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Oncology
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Patients
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • R&D
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Sales & Marketing
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Spotlight on
    • Frontiers Health 2022
    • The Future of Generics

Sign up for email newsletters and Deep Dive

 
 
rss facebook linkedin twitter
Pharmaphorum
About us Advertising Contact us
Contribute Cookie Policy Privacy Policy
Terms & Conditions Work for us
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company